LexaGene Holdings Inc. Quarterly Cost of Revenue in USD from Q3 2021 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: LexaGene Holdings Inc. quarterly Cost of Revenue history and growth rate from Q3 2021 to Q4 2022.
LexaGene Holdings Inc. Cost of Revenue for the quarter ending November 30, 2022 was $190K, a 27.8% increase year-over-year.

Cost of Revenue, Quarterly (USD)

Cost of Revenue, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2022		$190K	+$41.4K	+27.8%	Sep 1, 2022	Nov 30, 2022	10-Q	2023-01-17
Q3 2022		$247K	+$116K	+87.6%	Jun 1, 2022	Aug 31, 2022	10-Q	2022-10-18
Q4 2021		$149K			Sep 1, 2021	Nov 30, 2021	10-Q	2023-01-17
Q3 2021		$132K			Jun 1, 2021	Aug 31, 2021	10-Q	2022-10-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.